Perimeter Solutions (NYSE:PRM) versus BioLargo (NASDAQ:BLGO) Critical Comparison

BioLargo (NASDAQ:BLGOGet Free Report) and Perimeter Solutions (NYSE:PRMGet Free Report) are both small-cap construction companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, institutional ownership, profitability, valuation, analyst recommendations, risk and earnings.

Institutional and Insider Ownership

0.0% of BioLargo shares are owned by institutional investors. Comparatively, 89.9% of Perimeter Solutions shares are owned by institutional investors. 20.3% of BioLargo shares are owned by insiders. Comparatively, 8.7% of Perimeter Solutions shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Profitability

This table compares BioLargo and Perimeter Solutions’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
BioLargo -16.53% -58.35% -32.12%
Perimeter Solutions -14.12% 2.94% 1.41%

Volatility and Risk

BioLargo has a beta of 0.18, meaning that its stock price is 82% less volatile than the S&P 500. Comparatively, Perimeter Solutions has a beta of 2.02, meaning that its stock price is 102% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent recommendations and price targets for BioLargo and Perimeter Solutions, as provided by MarketBeat.com.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BioLargo 0 0 0 0 N/A
Perimeter Solutions 0 1 1 0 2.50

Perimeter Solutions has a consensus price target of $14.50, indicating a potential upside of 10.94%. Given Perimeter Solutions’ higher probable upside, analysts plainly believe Perimeter Solutions is more favorable than BioLargo.

Earnings & Valuation

This table compares BioLargo and Perimeter Solutions”s revenue, earnings per share and valuation.

Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
BioLargo $12.23 million 5.83 -$3.50 million ($0.03) -8.00
Perimeter Solutions $388.43 million 4.89 $67.49 million ($0.23) -56.83

Perimeter Solutions has higher revenue and earnings than BioLargo. Perimeter Solutions is trading at a lower price-to-earnings ratio than BioLargo, indicating that it is currently the more affordable of the two stocks.

Summary

Perimeter Solutions beats BioLargo on 9 of the 13 factors compared between the two stocks.

About BioLargo

(Get Free Report)

BioLargo, Inc. invents, develops, and commercializes various platform technologies. Its technologies solve challenging environmental problems comprising per – and polyfluoroalkyl substances (PFAS) water contamination, advanced water and wastewater treatment, industrial odor and volatile organic compounds control, air quality control, infection control, and myriad environmental remediation. The company provides full-service environmental engineering services. BioLargo, Inc. was incorporated in 1991 and is based in Westminster, California.

About Perimeter Solutions

(Get Free Report)

Perimeter Solutions, SA manufactures and supplies firefighting products and lubricant additives in the United States, Germany, and internationally. It operates in two segments, Fire Safety and Specialty Products. The Fire Safety segment provides fire retardants and firefighting foams, as well as specialized equipment and services for federal, state, provincial, local/municipal, and commercial customers. The Specialty Products segment produces and sells Phosphorus Pentasulfide, which is primarily used in the preparation of lubricant additives, including a family of compounds called Zinc Dialkyldithiophosphates. The company offers its products under the PHOS-CHEK, FIRE-TROL, AUXQUIMIA, and SOLBERG brands. Perimeter Solutions, SA was founded in 1963 and is headquartered in Clayton, Missouri.

Receive News & Ratings for BioLargo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioLargo and related companies with MarketBeat.com's FREE daily email newsletter.